CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- 4 Grant or award Chief Technology Officer acquired 10,516 shares (grant or award)
- 424B3 Offering Prospectus
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Grant or award Chief Technology Officer acquired 6,588 shares (grant or award)
- 4 Grant or award CMO acquired 6,950 shares (grant or award)
- 4 Grant or award CFO acquired 5,208 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Restatement
- 4 Grant or award Chief Technology Officer acquired 7,102 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 5,614 shares (grant or award)
- 4 Grant or award CMO acquired 7,492 shares (grant or award)
- NT 10-K Other NT 10-K
- 8-K/A Event Unregistered share sale
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
Page 13 of 71 · 1,401 filings